The importance of barrier strengthening therapy is supported by the outcome that a topical recombinant filaggrin delivery through cell penetrating peptide could restore the AD-like inflammation in filaggrin knockout mice [103]. The gene discussed is FLG; the disease is Alzheimer disease.